Antimicrobial agents

US9227966B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9227966-B2
Application numberUS-201414186516-A
CountryUS
Kind codeB2
Filing dateFeb 21, 2014
Priority dateApr 30, 2009
Publication dateJan 5, 2016
Grant dateJan 5, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a compound of formula I: or a salt or prodrug thereof, wherein Y, W, Z, Z 1 , Z 2 , Z 3 , Z 4 , and R 1 -R 12 have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as antibacterial agents.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula I: wherein: the dashed line between Y and W represents a single or double bond; when Y is —CR 2 —, Z is —(CR 13 2 ) 2 — or —CR 14 ═CR 14 — and R 12 is a bond; W is N or (NR a ) + X − ; when Y is —C═, Z is —(CR 13 2 ) 2 — or —CR 14 ═CR 14 — and R 12 is a bond; W is N + X − ; or X − is a pharmaceutically suitable counterion; Z 1 , Z 2 , Z 3 and Z 4 are each independently O, S or NR e ; or R 8 —Z 1 —, R 9 —Z 2 —, R 10 —Z 3 —, and R 11 —Z 4 — can each independently be H, optionally substituted aryl or optionally substituted heteroaryl; R 1 is H, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, aryloxy or arylthio; and R 2 is H or (C 1 -C 6 )alkyl, wherein any (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, and (C 1 -C 6 )alkylthio of R 1 and R 2 is optionally substituted with one or more groups selected from halo, cyano, oxo (═O), (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i , and wherein any aryloxy, or arylthio of R 1 and R 2 is optionally substituted with one or more groups selected from halo, cyano, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i ; at least one of R 3 , R 4 , R 5 , R 6 and R 7 is aryl, heteroaryl, aryl(C 1 -C 6 )alkyl, heteroaryl(C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkanoyl or heteroaryl(C 1 -C 6 )alkanoyl and the remainder of R 3 , R 4 , R 5 , R 6 and R 7 are independently H, halo, nitro, sulfo, —S(O) 2 NR n R p , —N(R n )S(O) 2 R p , —NR h R i optionally substituted alkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl, optionally substituted aryl, or optionally substituted heteroaryl; or R 3 is —Z 13 R 13′ wherein Z 13 is O, S or NR e and R 13′ is (C 1 -C 6 )alkyl, substituted (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl or —C(═O)NR f R g or R 13′ and R 9 together with the atoms to which they are attached form a 5 to 7 membered ring; or R 6 and R 7 together with the atoms to which they are attached form a 5 to 6 membered heterocycle wherein the heterocycle is optionally fused with an optionally substituted aryl; R 8 and R 9 are each independently, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl or —C(═O)NR f R g or R 8 and R 9 together with the atoms to which they are attached form a 5 to 7 membered ring; or R 8 —Z 1 — and R 9 —Z 2 — can each independently be H; R 10 and R 11 are each independently, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl or —C(═O)NR f R g or R 10 and R 11 together with the atoms to which they are attached form a 5 to 7 membered ring; or R 10 —Z 3 —, and R 11 —Z 4 — can each independently be H; each R 13 is independently H, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, aryloxy or arylthio wherein any (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, and (C 1 -C 6 )alkylthio of R 13 is optionally substituted with one or more groups selected from halo, cyano, oxo (═O), (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i , and wherein any aryloxy, or arylthio of R 13 is optionally substituted with one or more groups selected from halo, cyano, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i ; each R 14 is independently H, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, aryloxy or arylthio wherein any (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, and (C 1 -C 6 )alkylthio of R 14 is optionally substituted with one or more groups selected from halo, cyano, oxo (═O), (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i , and wherein any aryloxy, or arylthio of R 14 is optionally substituted with one or more groups selected from halo, cyano, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i ; R a is (C 1 -C 6 )alkyl wherein (C 1 -C 6 )alkyl is optionally substituted with one or more groups independently selected from halo, cyano, oxo (═O), (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i ; each R e is independently H or (C 1 -C 6 )alkyl wherein (C 1 -C 6 )alkyl is optionally substituted with one or more halo; R f and R g are each independently H, (C 1 -C 6 )alkyl, aryl, heteroaryl, aryl(C 1 -C 6 ) alkyl or heteroaryl(C 1 -C 6 ) alkyl; or R f and R g together with the nitrogen to which they are attached form a morpholino, piperazino, pyrrolidino or piperidino; R h and R i are each independently H, (C 1 -C 6 )alkyl, aryl, heteroaryl, aryl(C 1 -C 6 ) alkyl or heteroaryl(C 1 -C 6 ) alkyl; or R h and R i together with the nitrogen to which they are attached form a morpholino, piperazino, pyrrolidino or piperidino; and wherein R n and R p may be the same or different and are chosen from hydrogen, alkyl, arylalkyl, heteroarylalkyl, cycloalkyl, substituted cycloalkyl, aryl, heteroaryl and heterocyclic; or a salt or prodrug thereof, which is a compound of the following formula: or a salt thereof. 2. A compound of formula I: wherein: the dashed line between Y and W represents a single or double bond; when Y is —CR 2 —, Z is —(CR 13 2 ) 2 — or —CR 14 ═CR 14 — and R 12 is a bond; W is N or (NR a ) + X − ; when Y is —C═, Z is —(CR 13 2 ) 2 — or —CR 14 ═CR 14 — and R 12 is a bond; W is N + X − ; or X − is a pharmaceutically suitable counterion; Z 1 , Z 2 , Z 3 and Z 4 are each independently O, S or NR e ; or R 8 —Z 1 —, R 9 —Z 2 —, R 10 —Z 3 —, and R 11 —Z 4 — can each independently be H, optionally substituted aryl or optionally substituted heteroaryl; R 1 is H, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, aryloxy or arylthio; and R 2 is H or (C 1 -C 6 )alkyl, wherein any (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, and (C 1 -C 6 )alkylthio of R 1 and R 2 is optionally substituted with one or more groups selected from halo, cyano, oxo (═O), (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i , and wherein any aryloxy, or arylthio of R 1 and R 2 is optionally substituted with one or more groups selected from halo, cyano, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, carboxy, NO 2 , hydroxy, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkanoyloxy, aryl, heteroaryl, aryloxy, heteroaryloxy, and —NR h R i ; at least one of R 3 , R 4 , R 5 , R 6 and R 7 is aryl, heteroaryl, aryl(C 1 -C 6 )alkyl, heteroaryl(C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkanoyl or heteroaryl(C 1 -C 6 )alkanoyl and the remainder of R 3 , R 4 , R 5 , R 6 and R 7 are independently H, halo, nitro, sulfo, —S(O) 2 NR n R p , —N(R n )S(O) 2 R p , —NR h R i optionally substituted alkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl, optionally substituted aryl, or optionally substituted

Assignees

Inventors

Classifications

  • C07D455/03Primary

    containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine · CPC title

  • with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines · CPC title

  • Quaternary compounds · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9227966B2 cover?
The invention provides a compound of formula I: or a salt or prodrug thereof, wherein Y, W, Z, Z 1 , Z 2 , Z 3 , Z 4 , and R 1 -R 12 have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as antibacterial agents.
Who is the assignee on this patent?
Univ Rutgers
What technology area does this patent fall under?
Primary CPC classification C07D455/03. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).